G Pavlinkova Selected Research

Therapeutics

1/2001	Single-Dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using 131I-labeled multivalent CC49 single-chain fvs.
12/2000	Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic application.
9/2000	Relative position of the hexahistidine tag effects binding properties of a tumor-associated single-chain Fv construct.
5/2000	Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: expression, purification, and characterization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G Pavlinkova Research Topics

Disease

6	Neoplasms (Cancer) 10/2001 - 05/2000
3	Carcinoma (Carcinomatosis) 10/2001 - 12/2000
1	Adenocarcinoma 07/2000

Drug/Important Bio-Agent (IBA)

6	Monoclonal AntibodiesIBA 10/2001 - 05/2000
4	Single-Chain AntibodiesIBA 10/2001 - 05/2000
3	Indicators and Reagents (Reagents)IBA 10/2001 - 12/2000
2	RadiopharmaceuticalsIBA 01/2001 - 12/2000
2	Glycoproteins (Glycoprotein)IBA 12/2000 - 07/2000
2	His-His-His-His-His-His ((His)6)IBA 09/2000 - 05/2000
1	AntigensIBA 10/2001
1	Radioisotopes (Radionuclides)IBA 10/2001
1	AntibodiesIBA 01/2001
1	Immunoglobulin G (IgG)IBA 12/2000
1	Biological ProductsIBA 12/2000
1	tumor-associated antigen 72IBA 12/2000
1	Immunoglobulins (Immunoglobulin)IBA 07/2000
1	B72.3 antibodyIBA 07/2000

Therapy/Procedure

4	Therapeutics 01/2001 - 05/2000
1	Radioimmunotherapy 01/2001
1	Injections 01/2001
1	Immunotherapy 07/2000